https://www.selleckchem.com/pr....oducts/Glycyrrhizic-
04). Group mean fractional shortening fell by 1.5%/year over the 4 years before therapy, but this decreased to 0.9%/year over the first 4 years after starting therapy. Analysis of limited left ventricular ejection fraction measures showed similar but nonsignificant changes. Neither age at detection of left ventricular dysfunction nor fractional shortening percent at time of therapy initiation affected the beneficial response. The results support the international DMD recommendations of the time. This combination of cardiac med
Like
Comment
Share
